448
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs for diabetic macular edema

, MD MBA, , MD & , MD MPH

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Xiaobing Liu, Xiaoping Zhou, Weiqiong Song, Jiechun Zeng, Xiuxiu Niu & Ran Meng. (2023) The Diagnostic Value of Circulating VEGF in Diabetic Retinopathy in Asia: A Systematic Review and Meta-analysis. Ophthalmic Epidemiology 30:3, pages 230-238.
Read now
Stephen G Schwartz, Ingrid U Scott, Michael W Stewart & Harry W Flynn$suffix/text()$suffix/text(). (2016) Update on corticosteroids for diabetic macular edema. Clinical Ophthalmology 10, pages 1723-1730.
Read now
Jayabalan Nirmal, Krishna Radhakrishnan, Miguel Moreno, Jayaganesh V. Natarajan, Augustinus Laude, Tock Han Lim, Subbu Venkatraman & Rupesh Agrawal. (2016) Drug, delivery and devices for diabetic retinopathy (3Ds in DR). Expert Opinion on Drug Delivery 13:11, pages 1625-1637.
Read now

Articles from other publishers (10)

Dominika Podkowinski, Eva Orlowski‐Wimmer, Gerhard Zlabinger, Andreas Pollreisz, Anna‐Sophie Mursch‐Edlmayr, Siegfried Mariacher, Michael Ring & Matthias Bolz. (2019) Aqueous humour cytokine changes during a loading phase of intravitreal ranibizumab or dexamethasone implant in diabetic macular oedema. Acta Ophthalmologica 98:4.
Crossref
Kaiyan Zhang, Yingying Chen, Xuyang Sun, Qionglei Zhong, Lin Lin, Yuan Gao & Fanlin Hong. (2018) Periocular triamcinolone acetonide injection for treating polypoidal choroidal vasculopathy concurrent with hemorrhagic retinal detachment. Medicine 97:39, pages e12464.
Crossref
Anat Loewenstein, Usha Chakravarthy & Francesco Bandello. (2018) The 0.19 mg Fluocinolone Acetonide Intravitreal Implant – A Review on its Use in Diabetic Macular Oedema from the Association for Research in Vision and Ophthalmology Annual Meeting 2018. European Ophthalmic Review 12:2, pages 88.
Crossref
Michelle E. LeBlanc, Weiwen Wang, Xiuping Chen, Nora B. Caberoy, Feiye Guo, Chen Shen, Yanli Ji, Hong Tian, Hui Wang, Rui Chen & Wei Li. (2017) Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy. Journal of Experimental Medicine 214:4, pages 1029-1047.
Crossref
Stephen G. Schwartz & Harry W. FlynnJr.Jr.. (2016) Progressive Release of Vitreomacular Traction With Aflibercept. Ophthalmic Surgery, Lasers and Imaging Retina 47:5, pages 477-481.
Crossref
Xinde Chen, Kai Wang, Wenwei Xu, Quanxin Ma, Minli Chen, Lili Du, Mingguang Mo, Yiping Wang & Jianhua Shen. (2016) Discovery of Potent and Orally Active Lipoprotein-Associated Phospholipase A 2 (Lp-PLA 2 ) Inhibitors as a Potential Therapy for Diabetic Macular Edema . Journal of Medicinal Chemistry 59:6, pages 2674-2687.
Crossref
Despina Kokona, Panagiota-Christina Georgiou, Mihalis Kounenidakis, Foteini Kiagiadaki & Kyriaki Thermos. (2016) Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease. Neural Plasticity 2016, pages 1-12.
Crossref
Focke Ziemssen & Hansjürgen T. Agostini. 2016. Anti-Angiogenic Therapy in Ophthalmology. Anti-Angiogenic Therapy in Ophthalmology 89 130 .
Oren Tomkins-Netzer, Filis Ismetova, Asaf Bar, Sophie Seguin-Greenstein, Michal Kramer & Sue Lightman. (2015) Functional outcome of macular edema in different retinal disorders. Progress in Retinal and Eye Research 48, pages 119-136.
Crossref
Gillian M. Keating. (2015) Aflibercept: A Review of Its Use in Diabetic Macular Oedema. Drugs 75:10, pages 1153-1160.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.